PTC Therapeutics | PTCT - PE Price to Earnings


PTC Therapeutics reported 9.98 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Acadia Pharmaceuticals 10.08 1.53 Mar/2026
Alnylam Pharmaceuticals 80.04 90.66 Mar/2026
Amgen 19.84 5.47 Mar/2026
BioCryst Pharmaceuticals 6.06 1.07K Dec/2025
Biogen 13.7 0.32 Mar/2026
BioMarin Pharmaceutical 15.28 3.96 Mar/2026
Daiichi Sankyo 20.73 1.74 Dec/2025
Gilead Sciences 17.7 2.07 Mar/2026
Incyte 15.35 0.51 Mar/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Ironwood Pharmaceuticals 204.24 88.19 Dec/2024
Novartis 20.17 2.32 Mar/2026
Pfizer 9.32 5.16 Mar/2026
PTC Therapeutics 9.98 3.25 Dec/2025
Puma Biotechnology 13.93 44.88 Jun/2024
Roche Holding 16.09 3.51 Dec/2025
Sarepta Therapeutics 27.27 0 Dec/2025
TG Therapeutics 10.76 2.32 Dec/2025
Vertex Pharmaceuticals 25.82 0.33 Mar/2026
Xencor 29.92 3.22 Sep/2022